Advertisement
Citius Oncology, Inc. (CTOR)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 1.0300 |
| Open | 1.0366 |
| Bid | 1.1000 x 200 |
| Ask | 1.4100 x 200 |
| Day's Range | 1.0366 - 1.2000 |
| 52 Week Range | 0.9250 - 49.0000 |
| Volume | |
| Avg. Volume | 214,390 |
| Market Cap | 85.002M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1800 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireCitius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), today announced that Chairman and CEO Leonard Mazur will present and host one-on-one investor meetings at the H.C. Wainwright & Co. 26th Annual Global Investment Conference taking place September 9–11, 2024, in New York City.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.